CARTESIAN THERAPEUTICS INC (RNAC) Stock Cash Flow
NASDAQ:RNAC - Nasdaq - US8162123025 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -38.31M | -77.42M | -219.71M | 35.38M | -25.69M | |||
| Depreciation Amortization | 2.12M | 1.15M | 843.00K | 1.29M | 1.25M | |||
| Income Taxes - Deferred | N/A | 287.00K | -19.00M | N/A | N/A | |||
| Change In Working Capital | -6.50M | -5.79M | 4.97M | -60.38M | -48.19M | |||
| Interest Paid | N/A | 0.00 | 1.85M | 2.25M | 2.00M | |||
| Other non cash items | 11.54M | 58.10M | 181.74M | -7.92M | 12.25M | |||
| OPERATING CASH FLOW | -30.86M | -23.67M | -51.16M | -31.63M | -60.38M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -9.57M | -9.09M | -206.00K | -1.20M | -1.08M | |||
| Other Investing Activity | N/A | 351.00K | 34.81M | -13.80M | -16.05M | |||
| INVESTING CASH FLOW | -9.21M | -8.74M | 34.61M | -15.00M | -17.14M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | -27.46M | 0.00 | 0.00 | |||
| Stock Issued/Repurchased | 125.65M | 168.49M | 14.31M | 39.33M | 52.90M | |||
| Other Financing Activity | N/A | -66.00K | 0.00 | -110.00K | 0.00 | |||
| FINANCING CASH FLOW | 117.37M | 168.43M | -13.14M | 39.22M | 52.90M | |||
| Exchange Rate Effect | 16.00K | -21.00K | -53.00K | 20.00K | -3.00K | |||
| CHANGE IN CASH | 77.31M | 135.99M | -29.75M | -7.40M | -24.63M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -30.86M | -23.67M | -51.16M | -31.63M | -60.38M | |||
| Capital Expenditure | -9.57M | -9.09M | -206.00K | -1.20M | -1.08M | |||
| FREE CASH FLOW | -40.43M | -32.77M | -51.37M | -32.83M | -61.47M | |||
All data in USD